Xapien Secures $56 Million in Latest Funding Round
Xapien, a company specializing in automated AI-driven research for due diligence, has successfully raised $56 million in its latest funding round. The investment was led by Spectrum Equity, with participation from YFM Equity Partners. The funds will be used to expand Xapien's U.S. operations and further develop its platform.
Company Background
Xapien offers a platform that automates the due diligence process for legal, compliance, and procurement teams, among others. By leveraging AI, the platform can perform comprehensive research on individuals or companies globally, generating fully sourced and auditable reports in minutes.
Expansion Plans
The funding will primarily support Xapien's growth in the United States, where the company currently earns half of its revenue. Plans include expanding its Boston office and relocating CEO Chris Green and other senior leaders to the U.S. This move aims to strengthen the company's presence in the American market.
Leadership and Vision
Founded in 2018 by Shaun O'Mahony and Daniel Secretan, Xapien is currently led by CEO Chris Green. Green, who joined the company in 2022, emphasized the need for continuous visibility in third-party relationships, stating: βThird-party due diligence has remained stubbornly manual for twenty years, leaving organizations exposed.β The company serves a diverse clientele, including law firms, private banks, and multinational corporations.
Product Development
In addition to geographic expansion, Xapien is also working on 'Xapien Live,' a product designed for continuous monitoring of counterparty risk. Currently in beta, this feature aims to provide real-time insights rather than relying solely on periodic reviews.
Conclusion
With the new funding, Xapien is well-positioned to enhance its platform's capabilities and strengthen its market presence, particularly in the U.S. The company's focus on automating due diligence processes continues to resonate with organizations seeking efficiency and comprehensive risk analysis.